Vectarion: Full Drug Profile
Vectarion - General Information
A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem]
Pharmacology of Vectarion
Vectarion is a respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.
Additional information about Vectarion
Vectarion Indication: For the treatment of chronic obstructive pulmonary disease. Mechanism Of Action: Vectarion enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Almitrine Synonyms: Almitrine mesylate; Almitrine dimesylate; Almitrine bismesylate Drug Category: Respiratory System Agents Drug Type: Small Molecule; Approved Other Brand Names containing Almitrine: Vectarion; Duxil; Doxil; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of Vectarion: Not Available Chemical IUPAC Name: 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-N,N'-di(prop-2-enyl)-1,3,5-triazine-2,4-diamine Chemical Formula: C26H29F2N7 Almitrine on Wikipedia: https://en.wikipedia.org/wiki/Almitrine Organisms Affected: Humans and other mammals